NAT2
Chr 8ARN-acetyltransferase 2
Also known as: AAC2, NAT-2, PNAT
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019]
Primary Disease Associations & Inheritance
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Tolerant to missense variation
ClinVar
No ClinVar data available.
Protein Context — Lollipop Plot
NAT2 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
A Genotype-Phenotype Urothelial Cancer Registry
ACTIVE NOT RECRUITINGSulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
RECRUITINGExternal Resources
Links to major genomics databases and tools